You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Claims for Patent: 6,333,045

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,333,045

Title:	Aqueous liquid pharmaceutical composition comprised of gatifloxacin
Abstract:	There is provided an aqueous liquid pharmaceutical composition which comprises Gatifloxacin (chemical nomenclature: (.+-.)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazi nyl)-4-oxo-3-quinoline carboxylic acid) or its salt and disodium edetate. Further, there are provided a method for raising corneal permeability of Gatifloxacin, a method for preventing precipitation of Gatifloxacin crystals, and a method for preventing coloration of Gatifloxacin by incorporating disodium edetate into an aqueous liquid preparation containing Gatifloxacin or its salt.
Inventor(s):	Yasueda; Shinichi (Kobe, JP), Inada; Katsuhiro (Kobe, JP)
Assignee:	Senju Pharmaceutical Co., Ltd. (Osaka, JP) Kyorin Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:	09/529,882
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,333,045
Patent Claims:	1. An aqueous liquid pharmaceutical composition which comprises Gatifloxacin or its salt and disodium edetate. 2. The aqueous liquid pharmaceutical composition according to claim 1, wherein pH of the composition is within the range of 5 to 8. 3. The aqueous liquid pharmaceutical composition according to claim 1, where the composition is in the form of eye drops. 4. The aqueous liquid pharmaceutical composition according to claim 1, where the composition is in the form of ear drops. 5. The aqueous liquid pharmaceutical composition according to claim 1, where the composition is in the form of nasal drops. 6. A method for raising corneal permeability of Gatifloxacin which comprises incorporating disodium edetate into eye drops containing Gatifloxacin or its salt. 7. A method for preventing precipitation of Gatifloxacin crystals which comprises incorporating disodium edetate into an aqueous liquid preparation containing Gatifloxacin or its salt. 8. A method for preventing coloration of Gatifloxacin which comprises incorporating disodium edetate into an aqueous liquid preparation containing Gatifloxacin or its salt. 9. The aqueous liquid pharmaceutical composition according to claim 2, where the composition is in the form of eye drops. 10. The aqueous liquid pharmaceutical composition according to claim 2, where the composition is in the form of ear drops. 11. The aqueous liquid pharmaceutical composition according to claim 2, where the composition is in the form of nasal drops.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.